[Abstract Only] Cohort study: SGLT-2 inhibitors associated with an almost 3-fold increased risk for diabetic ketoacidosis 29 Jul, 2020 | 09:31h | UTC Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis: A Multicenter Cohort Study – Annals of Internal Medicine Commentary: Sodium glucose cotransporter-2 inhibitor use associated with increased risk of diabetic ketoacidosis – 2 Minute Medicine